Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Int J Surg. 2011;9(2):150-4. doi: 10.1016/j.ijsu.2010.10.010. Epub 2010 Oct 25.
Our initial experience of performing a single-incision laparoscopic-assisted (SILS) colectomy using a "home-made" multichannel port system is presented. Nine patients (5 women) with a median age of 67 years (range, 55-72 years) and a median body mass index of 21.2 kg/m(2) (range, 17.8-26.7 kg/m(2)) underwent the SILS colectomy for colon cancer between September 2009 and March 2010. The sites of the primary tumor were the ascending colon (n=2), hepatic flexure (n=1), transverse colon (n=2), and sigmoid colon (n=4). Each trocar was introduced intraperitoneally through each finger of a surgical glove attached to the wound protector, which was applied to a midline fasciotomy made via a ¾-circular periumbilical incision. If necessary, one to three radial splits were added to the incision. The colon was mobilized intracorporeally, and the vessels were ligated intra- or extracorporeally. All the patients underwent a curative segmental colectomy without conversion to a standard multiport laparoscopy or open surgery. The median operative time and blood loss were 140 min (range, 135-165 min) and 50 mL (range, 20-225 mL), respectively. The median number of harvested lymph nodes was 18 (range, 6-31). The pathological stages included stage 0 (n=2), stage I (n=6), and stage III (n=1). The median number of postoperative analgesic use was one (range, 0-6). No intra- or postoperative complications occurred in this series. Our SILS colectomy procedure seems feasible and safe in selected patients with colon cancer.
我们介绍了使用“自制”多通道端口系统进行单切口腹腔镜辅助(SILS)结肠切除术的初步经验。2009 年 9 月至 2010 年 3 月期间,9 名女性患者(5 名)中位年龄 67 岁(范围 55-72 岁)和中位体重指数 21.2kg/m²(范围 17.8-26.7kg/m²)因结肠癌接受 SILS 结肠切除术。原发性肿瘤部位为升结肠(n=2)、肝曲(n=1)、横结肠(n=2)和乙状结肠(n=4)。每个套管针通过附在伤口保护器上的手术手套的每个手指引入腹腔,将伤口保护器应用于通过半圆形脐周切口制成的中线筋膜切开术。如果需要,可在切口处添加一到三个放射状切口。将结肠在体内进行游离,血管在内或外进行结扎。所有患者均进行了治愈性节段性结肠切除术,无需转换为标准多孔腹腔镜或开放性手术。中位手术时间和出血量分别为 140 分钟(范围 135-165 分钟)和 50 毫升(范围 20-225 毫升)。中位淋巴结采集数为 18 个(范围 6-31 个)。病理分期包括 0 期(n=2)、1 期(n=6)和 3 期(n=1)。术后中位数使用镇痛剂的次数为 1 次(范围 0-6 次)。该系列中无术中或术后并发症。在选定的结肠癌患者中,我们的 SILS 结肠切除术似乎是可行且安全的。